Héctor Alejandro Ruiz-Moreno

Héctor Alejandro Ruiz-Moreno

Auto-generated profile, based on publicly available information

Héctor Alejandro Ruiz-Moreno

Grupo de Genómica de Microorganismos Emergentes, Dirección de Investigación en Salud Pública, Instituto Nacional de Salud

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
DÁDiego Alejandro Álvarez-Díaz
Diego Alejandro Álvarez-Díaz
AMAna Muñoz
Ana Muñoz
PTPilar Tavera-Rodríguez
Pilar Tavera-Rodríguez
MHMaría T. Herrera-Sepúlveda
María T. Herrera-Sepúlveda
HRHector Alejandro Ruiz-Moreno
Hector Alejandro Ruiz-Moreno
MMMarcela Mercado-Reyes
Marcela Mercado-Reyes
Global surveillance programs for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are showing the emergence of variants with mutations in the spike protein. Genomic and laboratory surveillance are important to determine if these variants may be more infectious or less susceptible to antiviral treatments and vaccine-induced antibodies. Three of the most predominant SARS-CoV-2 variants in Colombia during the epidemiological peaks of 2021 were isolated: Mu, a variant of interest; Gamma, a variant of concern; B.1.111, which lacks genetic markers associated with greater virulence. Microneutralization assays were performed by incubating 120 mean tissue culture infectious doses (TCID50) of each SARS-CoV-2 isolate with five two-fold serial dilutions of sera from 31 BNT162b2-vaccinated volunteers. The mean neutralization titer (MN50) was calculated by the Reed–Muench method. At the end of August, Mu represented 49% of coronavirus disease 2019 (COVID-19) cases in Colombia, followed by 25% of Gamma. In contrast, B.1.111 became almost undetectable. The evaluation of neutralizing antibodies suggests that patients vaccinated with BNT162b2 generate neutralizing antibody titers against the Mu variant at significantly lower concentrations relative to B.1.111 and Gamma. This study shows the importance of continuing surveillance programs of emerging variants, as well as the need to evaluate the neutralizing antibody response induced by other vaccines.

20 June 2015 in Oriental Journal of Chemistry
Verified
Journal Article
Open access
PDF file
HRHector Ruiz
Hector Ruiz
MZMonica Zambtrano
Monica Zambtrano
LGLiliana Giraldo
Liliana Giraldo
RSRocio Sierra
Rocio Sierra
Juan Carlos Moreno-PirajánJuan Carlos Moreno-Piraján
Juan Carlos Moreno-Piraján
Oriental Journal of Chemistry is a peer reviewed quarterly research journal of pure and applied chemistry. It publishes standard research papers in almost all thrust areas of current chemistry of academic and commercial importance. It provides a platform for rapid publication of quality research papers, reviews and chemistry letters. Oriental Journal of Chemistry is abstracted and indexed in almost all reputed National and International agencies.

1 May 2019 in Ecological Modelling
Verified
Journal Article
Closed access
HRHéctor Alejandro Ruiz-Moreno
Héctor Alejandro Ruiz-Moreno
ALAna María López-Tamayo
Ana María López-Tamayo
ACAlejandro Caro-Quintero
Alejandro Caro-Quintero
JHJohana Husserl
Johana Husserl
ABAndrés Fernando González Barrios
Andrés Fernando González Barrios

13 April 2023 in Viruses
Verified
Journal Article
Open access
PDF file
KLKatherine Laiton-Donato
Katherine Laiton-Donato
CGCamila Guzman-Cardozo
Camila Guzman-Cardozo
EPErik Perdomo-Balaguera
Erik Perdomo-Balaguera
LLLadys Esther Sarmiento Lacera
Ladys Esther Sarmiento Lacera
OTOrlando Torres-Fernandez
Orlando Torres-Fernandez
JUJose A Usme-Ciro
Jose A Usme-Ciro
The family Tymoviridae comprises positive-sense RNA viruses, which mainly infect plants. Recently, a few Tymoviridae-like viruses have been found in mosquitoes, which feed on vertebrate sources. We describe a novel Tymoviridae-like virus, putatively named, Guachaca virus (GUAV), isolated from Culex pipiens and Culex quinquefasciatus species of mosquitoes and collected in the rural area of Santa Marta, Colombia. After a cytopathic effect was observed in C6/36 cells, RNA was extracted and processed through the NetoVIR next-generation sequencing protocol, and data were analyzed through the VirMAP pipeline. Molecular and phenotypic characterization of the GUAV was achieved using a 5′/3′ RACE, transmission electron microscopy, amplification in vertebrate cells, and phylogenetic analysis. A cytopathic effect was observed in C6/36 cells three days post-infection. The GUAV genome was successfully assembled, and its polyadenylated 3′ end was corroborated. GUAV shared only 54.9% amino acid identity with its closest relative, Ek Balam virus, and was grouped with the latter and other unclassified insect-associated tymoviruses in a phylogenetic analysis. GUAV is a new member of a family previously described as comprising plant-infecting viruses, which seem to infect and replicate in mosquitoes. The sugar- and blood-feeding behavior of the Culex spp., implies a sustained contact with plants and vertebrates and justifies further studies to unravel the ecological scenario for transmission.

14 December 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
DÁDiego Alejandro Álvarez-Díaz
Diego Alejandro Álvarez-Díaz
AMAna Muñoz
Ana Muñoz
MHMaría T. Herrera-Sepúlveda
María T. Herrera-Sepúlveda
PTPilar Tavera-Rodríguez
Pilar Tavera-Rodríguez
KLKatherine Laiton-Donato
Katherine Laiton-Donato
MMMarcela Mercado-Reyes
Marcela Mercado-Reyes
Several SARS-CoV-2 variants of concern (VOC) and interest (VOI) co-circulate in Colombia, and determining the neutralizing antibody (nAb) responses is useful to improve the efficacy of COVID-19 vaccination programs. Thus, nAb responses against SARS-CoV-2 isolates from the lineages B.1.111, P.1 (Gamma), B.1.621 (Mu), AY.25.1 (Delta), and BA.1 (Omicron), were evaluated in serum samples from immunologically naïve individuals between 9 and 13 weeks after receiving complete regimens of CoronaVac, BNT162b2, ChAdOx1, or Ad26.COV2.S, using microneutralization assays. An overall reduction of the nAb responses against Mu, Delta, and Omicron, relative to B.1.111 and Gamma was observed in sera from vaccinated individuals with BNT162b2, ChAdOx1, and Ad26.COV2.S. The seropositivity rate elicited by all the vaccines against B.1.111 and Gamma was 100%, while for Mu, Delta, and Omicron ranged between 32 to 87%, 65 to 96%, and 41 to 96%, respectively, depending on the vaccine tested. The significant reductions in the nAb responses against the last three dominant SARS-CoV-2 lineages in Colombia indicate that booster doses should be administered following complete vaccination schemes to increase the nAb titers against emerging SARS-CoV-2 lineages.

26 December 2024 in APMIS
Verified
Journal Article
Closed access
MMMarcela Mercado-Reyes
Marcela Mercado-Reyes
DMDaza Marcela
Daza Marcela
RYRodríguez Peña Yazmín
Rodríguez Peña Yazmín
APAraque Muñoz Paula
Araque Muñoz Paula
CFCarlos Franco-Muñoz
Carlos Franco-Muñoz
PÁPiñeros Daza José Ángel
Piñeros Daza José Ángel